Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

NCT00635414 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: Esomeprazole
DRUG: Esomeprazole

Sponsor

AstraZeneca